Medical Equipment

Next Generation Sequencing Market Revenue Anticipated To Reach $28.59 Billion By 2030 With 15.1% CAGR

May 15, 2026May 19, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Much Larger Will The Next Generation Sequencing Market Become By 2030 Compared To 2026?

The next generation sequencing market size has seen a rapid increase in recent years. It is forecast to grow from $14.2 billion in 2025 to $16.31 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 14.9%. The expansion observed historically can be credited to increasing research activity in genomics, the declining costs associated with sequencing technologies, the expansion of molecular diagnostics laboratories, a rising demand for disease-associated genetic analysis, and the availability of advanced sequencing reagents.

The next generation sequencing market is anticipated to experience substantial growth over the coming years. It is projected to reach $28.59 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 15.1%. This growth during the forecast period is fueled by several factors, including the rising implementation of precision medicine initiatives, increased financial commitments to population genomics research, the broader application of NGS in cancer diagnostics, a heightened need for swift sequencing methods, and the greater incorporation of sequencing data into clinical decision-making systems. Key trends anticipated during the same period encompass the wider embrace of high-throughput sequencing platforms, an escalating requirement for clinical diagnostic sequencing, the increasing incorporation of AI-powered bioinformatics tools, an enlargement of targeted and personalized medicine uses, and a stronger emphasis on economically efficient sequencing workflows.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3990&type=smp

What Market Drivers Are Helping Shape The Next Generation Sequencing Market Expansion?

The rising demand for personalized medicine is anticipated to propel the expansion of the next-generation sequencing market moving forward. Personalized medicine, also known as precision medicine, is an innovative medical and healthcare approach that considers an individual’s distinct genetic, environmental, and lifestyle factors to customize medical decisions and treatments. Next-generation sequencing serves as a foundational technology in personalized medicine, facilitating the precise assessment of a person’s genetic makeup and the creation of tailored healthcare strategies. For instance, in February 2024, the Personalised Medicine Coalition, a US-based hospital and health care organization, reported that the FDA approved 16 new personalized treatments for rare disease patients in 2023, an increase from 6 in 2022. Consequently, the growing demand for personalized medicine is driving the growth of the next-generation sequencing market.

How Does Segment Analysis Break Down The Next Generation Sequencing Market Structure?

The next generation sequencing market covered in this report is segmented –

1) By Product: Instruments, Reagents And Kits, Software

2) By Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing, Other Sequencing Technologies

3) By Application: Diagnostics, Drug Discovery, Other Applications

Subsegments:

1) By Instruments: Sequencing Systems, Library Preparation Instruments, Quality Control Instruments

2) By Reagents And Kits: Sequencing Reagents, Library Preparation Kits, Amplification Kits

3) By Software: Data Analysis Software, Bioinformatics Software, Workflow Management Software

What Trends Are Impacting The Next Generation Sequencing Market?

Leading companies within the next-generation sequencing market are concentrating on creating advanced solutions, including hybrid long- and short-read sequencing, to improve genomic resolution and accuracy. This hybrid sequencing approach integrates the benefits of short reads, known for their high throughput and minimal error rates, with the structural information and comprehensive coverage offered by long reads. An illustrative example occurred in March 2023 when Illumina, a biotechnology company headquartered in the US, introduced the Illumina Complete Long Read Prep, Human assay, which incorporates its innovative Complete Long Read technology. This assay facilitates the generation of both long- and short-read data using a single Illumina instrument and is designed to be compatible with NovaSeq X Plus, NovaSeq X, and NovaSeq 6000 systems. Notable characteristics of the product encompass a more streamlined workflow requiring significantly less DNA input than other long-read platforms. It also integrates Illumina sequencing-by-synthesis (SBS) chemistry with DRAGEN secondary analysis, ensuring highly accurate whole-genome sequencing and providing access to difficult-to-map, challenging genic regions. Furthermore, it comes with a promotional price of US $1,350 per genome (when utilizing NovaSeq X Plus with a 25B flow cell), a cost that covers long- and short-read library preparation, sequencing, and cloud-based analysis.

Which Companies Form The Competitive Landscape Of The Next Generation Sequencing Market?

Major companies operating in the next generation sequencing market are Illumina Inc, Thermo Fisher Scientific Inc, Pacific Biosciences of California Inc, Oxford Nanopore Technologies Ltd, QIAGEN NV, Agilent Technologies Inc, PerkinElmer Inc, BGI Group, 10x Genomics Inc, Takara Bio Inc, New England Biolabs Inc, Twist Bioscience Corp, Element Biosciences Inc, Ultima Genomics Inc, SeqWell Inc, Integrated DNA Technologies Inc, LGC Limited, Bio-Rad Laboratories Inc, Zymo Research Corporation, NimaGen BV

Access The Complete Next Generation Sequencing Market Report:

https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-global-market-report

Which Region Is The Primary Market For The Next Generation Sequencing Market?

North America was the largest region in the next generation sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the next generation sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Next Generation Sequencing Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-global-market-report

Browse Through More Reports Similar to the Global Next Generation Sequencing Market 2026, By The Business Research Company

Clinical Oncology Next Generation Sequencing Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-oncology-next-generation-sequencing-global-market-report

Clinical Next Generation Sequencing Ngs Data Analysis Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-next-generation-sequencing-ngs-data-analysis-global-market-report

Dna Sequencing Market Report 2026

https://www.thebusinessresearchcompany.com/report/dna-sequencing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795